Akreos Adapt 1 (Bausch and Lomb Inc., Rochester, NY, USA), Memory Lens 2 (Ciba Vision, Duluth, GA, USA), EasyCare600 2 (Tekia Inc., Irvine, CA, USA), 47c 2 (Acrimed, now Oculentis, Berlin, Germany), and CF Acrylic lenses 2 (Humanoptics, Erlangen, Germany) in post-DSAEK calcification.
All of our patients required repeat injection of intracameral air to achieve graft attachment ('re-bubbling'), which is a consistent risk factor across these reports. Isolated cases of HA-IOL calcification in non-DSAEK patients where intra-cameral gas was used for other indications-such as C 3 F 8 and SF 6 for a Descemet's tear 3 and SF 6 for ocular hypotony 1 -support the role of intracameral gas in the pathogenesis of HA-IOL calcification.
We propose that the trauma of repeat surgery involved in re-bubbling may disrupt the blood-aqueous barrier, increasing the concentration of calcium ions. The consistent finding of calcification restricted to the central part of the optic not protected by iris, suggests that the gas bubble in physical contact with the IOL surface is an important biochemical trigger for calcification.
We have never encountered HA-IOL calcification in patients after routine cataract surgery or after DSAEK Abbreviations: ACIOL, anterior chamber intra-ocular lens; DSEK, Descemet's stripping endothelial keratoplasty; FED, Fuchs' endothelial dystrophy; HTN, hypertension; IHD, ischaemic heart disease; IOL, intra-ocular lens; Ind, indication; ocular comor, ocular co-morbidity of operated eye; PMHx, past medical history; re-bub, re-bubbled; T2DM, type 2 diabetes mellitus; VA, visual acuity.
with only one bubble of air. However, an institutional audit identified 10 patients with a Rayner HA-IOL who required a re-bubble after DSAEK. That four of these (all described in this report) developed subsequent lens calcification suggests a significant risk. We now use hydrophobic IOLs in patients with corneal pathology who may require DSAEK in future, given that IOLs with lower water content are less prone to calcification. 4,5
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Sir, Urrets À Zavalia syndrome as a complication of ocular hypotonia due to intravenous cidofovir treatment
We read the article written by Orssaud et al 1 published in your valuable journal.They reported a case of UrretsZavalia syndrome (UZS) after receiving intravenous cidofovir treatment for laryngotracheal papillomatosis. They reported that anterior uveitis was observed in both eyes and the authors prescribed topical steroid and topical atropine 1% twice a day. Despite discontinuation of topical atropine therapy, she developed UZS in the left eye. They related the fixed dilated pupil to ocular hypotonia. However, they used atropine for the treatment of anterior uveitis and the iatrogenic mydriasis is a more common reason for the UZS as described by Mocan et al 2 (although the other eye did not develop UZS). As they proposed, iris ischemia precipitated by iris dilation and strangulation of iris vessel and iatrogenic damage to the radial nerve fibers of the iris could result in UZS. 
